Unanchored simulated treatment comparison on survival outcomes using parametric and Royston-Parmar models with application to lenvatinib plus pembrolizumab in renal cell carcinoma
Abstract Background Population-adjusted indirect comparison using parametric Simulated Treatment Comparison (STC) has had limited application to survival outcomes in unanchored settings. Matching-Adjusted Indirect Comparison (MAIC) is commonly used but does not account for violation of proportional...
Saved in:
Main Authors: | Christopher G. Fawsitt, Janice Pan, Philip Orishaba, Christopher H. Jackson, Howard Thom |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | BMC Medical Research Methodology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12874-025-02480-x |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Meta-analysis of efficacy and safety of pembrolizumab for the treatment of advanced or recurrent cervical cancer
by: Xue Zhang, et al.
Published: (2024-12-01) -
Conflits, féminité et identités diasporiques. Le pouvoir de la représentation chez Pratibha Parmar et Gurinder Chadha
by: Amandine Ducray
Published: (2010-09-01) -
Developing a novel model for predicting overall survival in late-onset colon adenocarcinoma patients based on LODDS: a study based on the SEER database and external validation
by: Chen Chen, et al.
Published: (2025-01-01) -
Identification and Clinical Validation of High HSP60 Expression Predicts Poor Prognosis in Patients with Ovarian Cancer
by: Zheng M, et al.
Published: (2025-01-01) -
Effect of comorbidity classes on survival of patients with gastrointestinal tract cancer
by: Linna Gao, et al.
Published: (2025-02-01)